Corcept Therapeutics (CORT) Tops Q2 EPS by 2c; Offers FY22 Revenue Guidance
Go back to Corcept Therapeutics (CORT) Tops Q2 EPS by 2c; Offers FY22 Revenue Guidance| Corcept Therapeutics, Inc. (NASDAQ: CORT) | Delayed: 114.94 +4.65 (4.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $110.29 | 52 Week High | $10.00 | |||
| Open | $110.29 | 52 Week Low | $3.22 | |||
| Day High | $115.60 | P/E | N/A | |||
| Day Low | $109.00 | EPS | $-0.46 | |||
| Volume | 232,856 | |||||
